| Literature DB >> 33924446 |
Noelle T Abbott1, Carolyn J Baker1, Conan Chen2, Thomas T Liu2, Tracy E Love1,3.
Abstract
Within the aphasia literature, it is common to link location of lesioned brain tissue to specific patterns of language impairment. This has provided valuable insight into the relationship between brain structure and function, but it does not capture important underlying alterations in function of regions that remain structurally intact. Research has demonstrated that in the chronic stage of aphasia, variable patterns of reduced cerebral blood flow (CBF; hypoperfusion) in structurally intact regions of the brain contribute to persisting language impairments. However, one consistent issue in this literature is a lack of clear consensus on how to define hypoperfusion, which may lead to over- or underestimation of tissue functionality. In the current study, we conducted an exploratory analysis in six individuals with chronic aphasia (>1 year post-onset) using perfusion imaging to (1) suggest a new, individualized metric for defining hypoperfusion; (2) identify the extent of hypoperfused tissue in perilesional bands; and (3) explore the relationship between hypoperfusion and language impairment. Results indicated that our individualized metric for defining hypoperfusion provided greater precision when identifying functionally impaired tissue and its effects on language function in chronic aphasia. These results have important implications for intervention approaches that target intact (or impaired) brain tissue.Entities:
Keywords: cerebral blood flow; chronic aphasia; hypoperfusion; individual differences; language behavior; perfusion imaging; perilesional tissue; stroke
Year: 2021 PMID: 33924446 PMCID: PMC8070458 DOI: 10.3390/brainsci11040491
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Demographic information and language assessment scores.
| Participant | Sex/Age/Years Post-Stroke | Education (Years) | Aphasia | BDAE-3 2 Severity (1 = Severe, 5 = Mild) | BDAE-AC 3 | WAB-AQ 4 | WAB-AC 5 |
|---|---|---|---|---|---|---|---|
| S01 | M/55/15 | 17 | Broca’s | 2 | 21 | 67.7 | 72 |
| S02 | M/67/9 | 20 | Broca’s | 3 | 65 | 82.6 | 91 |
| S03 | F/65/7 | 16 | Anomic | 4 | 90 | 95.8 | 100 |
| S04 | M/59/4 | 12 | Broca’s | 2 | 35 | 28.2 * | 80 |
| S05 | M/58/5 | - | Broca’s | 2 | 11 | 50.8 | 72 |
| S06 | F/76/6 | 12 | Anomic | 3 | 78 | 88.2 | 89 |
1 Based on WAB-R subtypes. 2 BDAE-3: Boston Diagnostic Aphasia Examination—3rd edition severity rating scale (1 = severe, 5 = mild); 3 BDAE-AC: auditory comprehension composite (AC) score based on the BDAE-3 auditory comprehension subtests; 4 WAB-AQ: Western Aphasia Battery-Aphasia Quotient, measure of aphasia severity derived from the WAB-Revised (R) assessment (<50 = severe, 51–70 = moderate, >71 = mild); 5 WAB-AC: auditory comprehension composite (AC) score based on the WAB-R auditory comprehension subtests. * WAB-AQ score was low due to an inability to perform the repetition and overt naming tasks. Note: Education information was unavailable for S05.
A summary of lesion information and brain volume for each participant.
| Participant | Lesion Location | LH 1 Brain | RH 2 Brain | Lesion Volume | % Lesion in LH |
|---|---|---|---|---|---|
| S01 | L inferior and posterior frontal lobe w/subcortical extension; anterior, superior and middle temporal lobe; inferior, anterior and posterior parietal lobe | 540.90 | 619.85 | 172.52 | 31.90 |
| S02 | L inferior and posterior frontal lobe w/subcortical extension; superior and middle temporal lobe; inferior and anterior parietal lobe | 557.25 | 611.24 | 146.27 | 26.25 |
| S03 | L posterior frontal lobe with subcortical structures | 426.01 | 517.34 | 23.26 | 5.46 |
| S04 | L medial and posterior frontal lobe; superior and middle temporal lobe; anterior parietal lobe | 544.43 | 580.05 | 66.03 | 12.13 |
| S05 | L inferior and posterior frontal lobe w/subcortical extension; superior and middle temporal lobe; anterior, posterior, superior and inferior parietal lobe; middle and superior occipital lobe | 436.17 | 487.67 | 180.60 | 41.41 |
| S06 | L superior temporal lobe | 352.06 | 389.63 | 12.06 | 3.43 |
1 LH: left hemisphere; 2 RH: right hemisphere; cc3: cubic centimeters; percent (%) lesion in LH was calculated by dividing the lesion volume by the LH brain volume.
Figure 1Lesion overlay maps illustrating lesion location and extent in our sample of 6 participants. Heat maps correspond to the number of patients that have a lesion in that area. Lesions are overlaid on labeled axial slices (z-coordinates) from the SPM152 template; SPM: Statistical Parametric Mapping. Images are presented in radiological view (i.e., left hemisphere is on the right side).
CBF (mL/100 g tissue/min) values in gray matter for the whole brain, left (CBFLH) and right (CBFRH) hemispheres. Functionally compromised brain tissue (bolded) was calculated based on 1.5 standard deviations (SD) below mean CBFRH. A perfusion ratio was calculated by dividing CBFLH by CBFRH to demonstrate the extent of differences between the two hemispheres. Values < 1 indicate lower CBFLH and values > 1 indicate greater CBFLH. * Indicates a significant difference at p < 0.05.
| Group-Level | S01 | S02 | S03 | S04 | S05 | S06 | |
|---|---|---|---|---|---|---|---|
| Whole Brain CBF mean (SD) | 50.97 (16.61) | 30.06 (10.69) | 62.66 (13.73) | 44.18 (12.48) | 56.44 (11.13) | 58.62 (14.45) | 54.42 (12.37) |
| Mean CBFLH (SD) | 46.94 (16.14) | 24.29 (8.85) | 58.36 (13.26) | 43.14 (12.51) | 54.44 (11.68) | 51.18 (11.68) | 50.95 (11.88) |
| Median CBFLH | 47.73 | 23.63 | 60.46 | 43.55 | 57.05 | 52.1 | 51.31 |
| Mean CBFRH (SD) | 54.92 (16.14) | 35.71 (9.29) | 66.78 (13.02) | 45.23 (12.51) | 58.35 (10.35) | 65.56 (13.39) | 57.90 (11.99) |
| Median CBFRH | 57.04 | 34.9 | 68.75 | 43.91 | 60.55 | 67.57 | 60.11 |
|
|
|
|
|
|
|
|
|
| F(1,5) = 32.03, | t(44) = −5.94, | t(44) = −3.00, | t(44) = −0.79, | t(44) = −1.66, | t(44) = −5.29, | t(44) = −2.76, | |
| Perfusion Ratio | 0.85 | 0.68 | 0.87 | 0.95 | 0.93 | 0.78 | 0.88 |
Figure 2A comparison between mean CBF in remaining intact tissue of the left hemisphere (CBFLH) and percent lesion damage in the left hemisphere (LH). There is no clear relationship between mean CBFLH and lesion size in our sample which suggests that CBF in remaining intact tissue is not influenced by lesion size alone.
Figure 3Individualized CBF threshold maps for each participant. The dark purple flag indicates when tissue is hypoperfused based on the individually defined approach of 1.5 SD below CBFRH. The light purple flag indicates average CBFRH. The gray boxes show CBF values for each of the four 3mm perilesional bands. As can be seen in the figure, the 0–3mm band is either at or below the individually defined threshold for hypoperfusion for each participant.
A comparison of hypoperfused ROIs based on individualized (blue shading) and standard (red font) threshold values at both the group and individual level. The numbers in the table represent mean CBF (mL/100 g tissue/min) in that left hemisphere (LH) ROI. * values of 0 likely reflect a small number of voxels that were not captured in the original lesion mask due to their proximity to large sulci.
| Language ROI (LH) | Group | S01 | S02 | S03 | S04 | S05 | S06 |
|---|---|---|---|---|---|---|---|
| Functionally compromised CBF | 30.71 | 21.77 | 47.25 | 26.46 | 42.83 | 45.48 | 39.91 |
| Pars Opercularis (BA44) | 46.12 | 30.64 | 40.79 | 30.27 | 57.12 | 70.49 | 47.43 |
| Pars Triangularis (BA45) | 54.77 | 22.31 | 76.19 | 50.10 | 67.64 | 55.08 | 57.32 |
| Pars Orbitalis (BA47) | 52.38 | 25.98 | 67.44 | 39.85 | 61.50 | 56.79 | 62.75 |
| Insula | 41.36 |
| 56.07 | 25.27 | 48.78 | 52.07 | 49.46 |
| Superior Temporal Lobe (STL) | 42.89 | 44.20 | 40.35 | 48.72 | 29.94 | 45.00 | 49.13 |
| Superior Temporal Pole (STP) | 34.74 | 21.83 | 43.98 | 43.55 | 32.93 | 44.43 | 21.71 |
| Middle Temporal Lobe (MTL) | 40.70 | 21.62 | 47.57 | 53.40 | 46.18 | 31.45 | 44.00 |
| Middle Temporal Pole (MTP) | 32.65 |
| 43.12 | 35.06 | 31.82 | 46.67 | 23.58 |
| Supramarginal Gyrus (SMG) | 31.86 | 25.21 | 49.90 | 39.45 | 36.28 |
| 40.34 |
| Angular Gyrus (AG) | 45.78 | 20.65 | 79.13 | 56.83 | 49.95 |
| 68.15 |
| Inferior Parietal Lobule (IPL) | 43.22 |
| 64.30 | 52.26 | 51.19 |
| 53.31 |
| Number of ROIs hypoperfused with | 0 out | 3 out | 0 out | 0 out | 0 out | 3 out | 0 out |
| Number of ROIs hypoperfused with | 0 out | 5 out | 4 out | 1 out | 4 out | 6 out | 2 out |
A comparison of individualized and standard hypoperfusion approaches in structurally intact brain tissue. Percentages represent the amount of tissue remaining in each ROI after accounting for the lesion. Blue shading = hypoperfused based on 1.5 standard deviations below mean CBFRH. Red text = hypoperfused based on standard threshold values (<20 mL/100 g tissue/min). The total number of ROIs categorized as hypoperfused using each hypoperfusion metric is reported at the bottom of the table.
| Language ROI | S01 | S02 | S03 | S04 | S05 | S06 |
|---|---|---|---|---|---|---|
| Pars Opercularis (BA44) | 14.3% | 27.8% | 83.3% | 92.2% | 97.0% | 99.9% |
| Pars Triangularis (BA45) | 59.6% | 98.9% | 99.6% | 100.0% | 70.9% | 100.0% |
| Pars Orbitalis (BA47) | 85.7% | 100.0% | 100.0% | 100.0% | 79.5% | 100.0% |
| Insula |
| 53.0% | 96.8% | 59.3% | 70.4% | 99.0% |
| Superior Temporal Lobe (STL) | 15.6% | 3.7% | 100.0% | 39.0% | 25.9% | 74.7% |
| Superior Temporal Pole (STP) | 29.8% | 93.3% | 100.0% | 98.0% | 100.0% | 100.0% |
| Middle Temporal Lobe (MTL) | 82.1% | 30.3% | 100.0% | 59.7% | 41.9% | 93.5% |
| Middle Temporal Pole (MTP) |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Supramarginal Gyrus (SMG) | 7.6% | 30.1% | 99.9% | 54.6% |
| 51.2% |
| Angular Gyrus (AG) | 94.8% | 98.2% | 100.0% | 66.7% |
| 91.0% |
| Inferior Parietal Lobule (IPL) |
| 76.4% | 100.0% | 87.6% |
| 95.5% |
| Number of ROIs hypoperfused with | 3 out of 11 | 0 out of 11 | 0 out of 11 | 0 out of 11 | 3 out of 11 | 0 out of 11 |
| Number of ROIs hypoperfused with | 5 out of 11 | 4 out of 11 | 1 out of 11 | 4 out of 11 | 6 out of 11 | 2 out of 11 |
A comparison of significant correlations between frontal, parietal and temporal ROIs and language measures using individual versus standard (<20 mL/100 g of tissue/min) hypoperfusion metrics. Gray shading represents significant correlations using the individualized approach not apparent with standard cutoffs. 1 WAB-AQ: Western Aphasia Battery-Aphasia Quotient; 2 WAB-AC: auditory comprehension composite (AC) score; 3 BDAE-AC: auditory comprehension (AC) composite score; * p < 0.05; ** p < 0.01; + p < 0.06; ^ no hypoperfusion found for any of the participants.
| Individual Cutoffs | Standard Cutoffs | |||||
|---|---|---|---|---|---|---|
| WAB-AQ 1 | WAB-AC 2 | BDAE-AC 3 | WAB-AQ 1 | WAB-AC 2 | BDAE-AC 3 | |
| WAB-AQ 1 | 1 | 1 | ||||
| WAB-AC 2 | 0.71 + | 1 | 0.71 + | 1 | ||
| BDAE-AC 3 | 0.77 * | 0.97 ** | 1 | 0.77 * | 0.97 ** | 1 |
| Pars Opercularis (BA44) | −0.26 | −0.31 | −0.23 | −0.26 | −0.31 | −0.23 |
| Pars Triangularis (BA45) ^ | -- | -- | -- | -- | -- | -- |
| Pars Orbitalis (BA47) ^ | -- | -- | -- | -- | -- | -- |
| Insula | −0.39 | −0.14 | −0.13 | 0.02 | 0.52 | 0.44 |
| Superior Temporal Lobe (STL) | 0.64 | 0.29 | 0.44 | 0 | 0 | 0 |
| Superior Temporal Pole (STP) | 0.39 | 0.14 | 0.13 | −0.37 | −0.22 | −0.43 |
| Middle Temporal Lobe (MTL) | 0.29 | 0.83 * | 0.82 * | 0.023 | 0.52 | 0.44 |
| Middle Temporal Pole (MTP) | 0.14 | 0.14 | 0.01 | 0.02 | 0.52 | 0.44 |
| Supramarginal Gyrus (SMG) | 0.89 ** | 0.55 | 0.65 | 0.34 | 0.52 | 0.59 |
| Angular Gyrus | 0.29 | 0.83 * | 0.82 * | 0.29 | 0.83 * | 0.82 * |
| Inferior Parietal Lobule (IPL) | 0.29 | 0.83 * | 0.82 * | 0.29 | 0.83 * | 0.82 * |
Figure 4Individual CBF patterns in ROIs that were significantly correlated with the BDAE-AC (left) and the WAB-AC (right) and percentile scores. Dotted boxes represent individuals with Broca’s aphasia who performed the worst on the two auditory comprehension measures. Dashed boxes represent individuals with Broca’s aphasia who performed poorly on the BDAE-AC but not the WAB-AC. Solid boxes represent individuals with Anomic aphasia who performed well on the two auditory comprehension measures. MTL: medial temporal lobe; IPL: inferior parietal lobe; AG: angular gyrus. Note: S05 had a CBF value near zero in the AG, likely due to a small number of voxels not included in the lesion mask.
Mean CBF (mL/100 g tissue/min) values in the four left hemisphere (CBFLH) and four right hemisphere (CBFRH) perilesional bands. Paired t-test results are given for CBFLH versus CBFRH differences. A perfusion ratio was calculated by dividing CBFLH by CBFRH to demonstrate the extent of differences within perilesional bands between the two hemispheres. Values < 1 indicate lower CBFLH, and values > 1 indicate greater CBFLH. Bold values indicate that there was a significant difference in CBF values between the two hemispheres at p < 0.05. * indicates that the p-value survived Bonferroni correction at p < 0.0125.
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
|
| ||||||
| Mean CBFLH (SD) | 20.04 (19.41) | 44.47 (28.36) | 25.71 (19.66) | 41.30 (22.24) | 47.53 (21.68) | 40.22 (22.70) |
| Mean CBFRH (SD) | 41.81 (23.56) | 68.00 (24.90) | 49.81 (23.81) | 62.83 (21.72) | 64.07 (25.00) | 61.23 (22.38) |
| t(826) = | t(880) = | t(297) = | t(138) = | t(650) = | t(307) = | |
| CBFLH/CBFRH ratio | 0.48 | 0.65 | 0.52 | 0.66 | 0.74 | 0.66 |
|
| ||||||
| Mean CBFLH (SD) | 25.21 (21.28) | 62.51 (28.19) | 38.86 (22.52) | 55.38 (23.46) | 59.24 (22.75) | 53.02 (26.57) |
| Mean CBFRH (SD) | 39.13 (24.47) | 67.99 (25.61) | 41.00 (24.48) | 59.10 (22.11) | 65.32 (25.36) | 63.90 (24.83) |
| t(768) = | t(612) = | t(273) = | t(408) = | t(644) = | t(247) = | |
| CBFLH/CBFRH ratio | 0.64 | 0.92 | 0.95 | 0.94 | 0.91 | 0.83 |
|
| ||||||
| Mean CBFLH (SD) | 24.70 (18.75) | 62.67 (26.97) | 43.73 (23.87) | 51.97 (21.40) | 57.83 (20.71) | 52.38 (27.69) |
| Mean CBFRH (SD) | 35.74 (21.92) | 64.82 (29.21) | 44.75 (23.90) | 58.63 (23.69) | 62.40 (24.31) | 60.10 (25.54) |
| t(754) = | t(570) = | t(347) = | t(451) = | t(601) = | t(294) = | |
| CBFLH/CBFRH ratio | 0.69 | 0.97 | 0.98 | 0.89 | 0.93 | 0.87 |
|
| ||||||
| Mean CBFLH (SD) | 24.66 (17.72) | 64.10 (27.37) | 46.45 (22.87) | 57.11 (22.40) | 61.17 (25.37) | 47.99 (21.52) |
| Mean CBFRH (SD) | 32.96 (21.49) | 62.20 (29.14) | 44.01 (25.63) | 58.09 (23.93) | 56.61 (24.05) | 59.47 (25.03) |
| t(768) = | t(589) = | t(348) = | t(496) = | t(526) = | t(420) = | |
| CBFLH/CBFRH ratio | 0.75 | 1.03 | 1.06 | 0.98 | 1.08 | 0.81 |
An illustration of the six planned comparisons across the perilesional bands.
| Planned Comparisons | |||
|---|---|---|---|
| 3–6 mm | 6–9 mm | 9–12 mm | |
| 0–3 mm | X | X | X |
| 3–6 mm | X | X | |
| 6–9 mm | X | ||
Comparisons of CBF patterns at each perilesional band for group and individual levels. 1 Group-level analyses were conducted with mean CBF values across all participants. Underlined p-values reflect trends at the p < 0.06 level. Bolded values are significant at p < 0.05. * indicates that the p-value survived Bonferroni correction at p < 0.0083.
| Perilesional Bands | Group Level 1 | S01 | S02 | S03 | S04 | S05 | S06 |
|---|---|---|---|---|---|---|---|
| 0–3 mm to 3–6 mm | t(10) = −1.69, | t(692) = −3.40, | t(656) = −8.71, | t(244) = −4.92, | t(186) = −4.91, | t(573) = −6.33, | t(233) = −4.46, |
| 0–3 mm to 6–9 mm | t(10) = −1.74, | t(703) = −3.27, | t(598) = −8.74, | t(287) = −7.03, | t(162) = −3.91, | t(550) = −5.72, | t(270) = −4.30, |
| 0–3 mm to 9–12 mm | t(10) = −1.85, | t(731) = −3.41, | t(609) = −9.40, | t(283) = −8.23, | t(160) = −5.83, | t(513) = −6.76, | t(387) = −3.48, |
| 3–6 mm to 6–9 mm | t(10) = 0.01, | t(673) = 0.33, | t(579) = −0.07, | t(274) = −1.77, | t(402) = 1.56, | t(540) = 0.75, | t(263) = 0.19, |
| 3–6 mm to 9–12 mm | t(10) = −0.15, | t(670) = 0.37, | t(586) = −0.69, | t(268) = −2.80, | t(414) = −0.80, | t(522) = −0.93, | t(222) = 1.79, |
| 6–9 mm to 9–12 mm | t(10) = −0.17, | t(695) = 0.03, | t(557) = −0.62, | t(321) = −1.04, | t(485) = −2.60, | t(498) = −1.64, | t(258) = 1.59, |